{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-075294","form_type":"8-K","ticker":"UTHR","cik":"0001082554","company_name":"UNITED THERAPEUTICS Corp","filed_at":"2022-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.667708+00:00","generated_at":"2026-06-24T22:32:37.426756+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Shareholders approve 500,000-share increase and extension of 2015 Stock Incentive Plan to 2032","bullets":["Plan share reserve increased by 500,000 to 11.5M shares; expiration extended to April 25, 2032.","All 9 director nominees elected with majority vote; advisory say-on-pay passed with 38.9M for, 0.7M against.","Plan amendment received 34.8M votes for (85.8% of votes cast); Ernst & Young ratified as auditor for 2022.","Amendment effective June 27, 2022; prior plan was approved by shareholders in June 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-075294","json":"https://secwatch.observer/filing/0001104659-22-075294.json","markdown":"https://secwatch.observer/filing/0001104659-22-075294.md","text":"https://secwatch.observer/filing/0001104659-22-075294.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1082554/000110465922075294/0001104659-22-075294-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/000110465922075294/tm2219474d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T22:32:37.426756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}